STAT stories you may have missed
Families, doctors, and a pharmaceutical company are all confronting a philosophically fraught question: Is it ethical to make a little person taller?
Under French law, having a direct-to-consumer genetic test can, technically speaking, put you at risk of being fined about $4,140. Activists are fighting to lift the ban.
In Silicon Valley, digital health companies are valued for their sleek technology. But it's remote health coaches — many of them women, many of them living in America's heartland — that power the operation.
Mass. Gov. Charlie Baker is a one-time health insurance executive armed with a long list of ideas about how to retool an industry he knows well.
A federal regulator is investigating whether Google followed the federal privacy law known as HIPAA when it collected millions of Ascension patient records.
Dollar Tree purchased drugs from foreign companies that failed to follow manufacturing standard, displaying a pattern of serious violations, the FDA said in a warning letter.
Opinion: If America paid for water or electricity the way it pays for drugs, tens of millions of Americans would be living in squalor. The Booker-Sanders-Harris drug affordability bureau could help, write Jessica Sagers and Peter Kolchinsky, investors with RA Capital Management.
Under French law, having a direct-to-consumer genetic test can, technically speaking, put you at risk of being fined about $4,140. Activists are fighting to lift the ban.
In Silicon Valley, digital health companies are valued for their sleek technology. But it's remote health coaches — many of them women, many of them living in America's heartland — that power the operation.
Mass. Gov. Charlie Baker is a one-time health insurance executive armed with a long list of ideas about how to retool an industry he knows well.
A federal regulator is investigating whether Google followed the federal privacy law known as HIPAA when it collected millions of Ascension patient records.
Dollar Tree purchased drugs from foreign companies that failed to follow manufacturing standard, displaying a pattern of serious violations, the FDA said in a warning letter.
Opinion: If America paid for water or electricity the way it pays for drugs, tens of millions of Americans would be living in squalor. The Booker-Sanders-Harris drug affordability bureau could help, write Jessica Sagers and Peter Kolchinsky, investors with RA Capital Management.
No hay comentarios:
Publicar un comentario